Trials / Completed
CompletedNCT02892591
Cannabis Versus Oxycodone for Pain Relief
A Double-Blind, Placebo-Controlled Crossover Study Comparing the Analgesic Efficacy of Cannabis Versus Oxycodone
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
This study investigates the ability of cannabis to reduce chronic back and neck pain and to reduce sensitivity to an acute painful stimulus. Cannabis will be compared to both oxycodone and a placebo.
Detailed description
This study investigates the ability of cannabis to reduce chronic back and neck pain and to reduce sensitivity to an acute painful stimulus. Cannabis will be compared to both oxycodone and a placebo. Some inclusion/exclusion criteria are purposely omitted at this time to preserve scientific integrity. They will be included after the trial is complete.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cannabis | vaporized plant material |
| DRUG | Oxycodone | oral capsule |
| DRUG | Placebo for Cannabis | vaporized placebo plant material |
| DRUG | Placebo for Oxycodone | oral placebo capsule |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2023-06-07
- Completion
- 2023-06-07
- First posted
- 2016-09-08
- Last updated
- 2024-02-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02892591. Inclusion in this directory is not an endorsement.